HHS eases certain practice requirements for opioid use disorder treatment

Apr 27, 2021 - 03:20 PM
HHS Logo web sized 900x400

The Department of Health and Human Services today released new  for administering buprenorphine, which exempt from certain training and certification requirements eligible physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives who wish to treat up to 30 patients at any time. The clinicians must be licensed under state law and possess a federal waiver to practice this form of medication-assisted treatment and a valid Drug Enforcement Administration registration. Some states also require a DEA-registered physician to supervise or collaborate with the practitioner. Eligible clinicians who wish to treat more patients may seek a waiver under the established . 

鈥淭hese new guidelines are an important step forward in reducing barriers to treatment and will ultimately help more people find recovery,鈥  Tom Coderre, acting assistant secretary for mental health and substance use at HHS. 
 

Related News Articles

Headline
FDA approves first-in-class non-opioid painkiller聽
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to鈥
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,鈥
Headline
AHA podcast: Thinking Outside the Box to Reduce Behavioral Health Stigma and Disparities聽
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to鈥
Headline
'Take Back Day' Oct. 28 to dispose safely of prescription drugs
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and鈥
Headline
Agencies target unapproved pharmaceutical products from India
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from鈥
Headline
AHA sends SUPPORT Act reauthorization recommendations to House committee鈥
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and鈥